School of Medicine
Showing 2,731-2,740 of 12,884 Results
-
Julia Donahue
Senior Project Manager, Med/Stanford Center for Clinical Research
BioJulia Donahue is a Clinical Research Manager with the Stanford Center for Clinical Research (SCCR) at Stanford University. Julia has been working with SCCR since 2021. Her professional interests include Project Management, Digital Health, Study-Startup, Hospital-Based Research, and Decentralized Clinical Trials. She has extensive clinical trial experience in multiple fields, including but not limited to cardiology, dermatology, endocrinology, infectious diseases, psychiatry, and rheumatology.
Julia graduated with honors from McGill University in 2016, where her primary research interests were in neurodevelopmental disorders and autobiographical memory. -
Krista Donaldson
Casual - Non-Exempt, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordDirector of Innovation to Impact, Byers Center for Biodesign
-
Sarah S. Donaldson, MD
Catharine and Howard Avery Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsCombined Modality Treatment of Cancer
Late Effects of Treatment
Genetic Effects of Cancer
Rhabdomyosarcoma
Hodgkins Disease
Pediatric Radiation Oncolgy
Pediatric Oncolgy
Breast Cancer
Conformal Radiotherapy/IMRT
Radiotherapy for Benign Diseases -
Chunyang Dong
Postdoctoral Scholar, Psychiatry
BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.
-
Fei Dong
Associate Professor of Pathology
BioDr. Dong is the Director of Molecular Pathology at Stanford Health Care. The Molecular Pathology laboratory offers a broad menu of clinical diagnostic tests ranging from PCR to next generation sequencing. Dr. Dong's academic interests include the clinical implementation of laboratory developed tests, the development of novel informatics algorithms, and characterization of disease by molecular methods. Before arriving at Stanford, Dr. Dong was on faculty at Brigham and Women’s Hospital/Harvard Medical School for nine years, where he established a track record in education and mentorship and was the recipient of both the Anatomic Pathology and Clinical Pathology resident teaching awards. Dr. Dong has served on committees for the Association for Molecular Pathology, the Clinical and Laboratory Standards Institute, and the United States and Canadian Academy of Pathology. He serves on the editorial boards of multiple scientific journals and is an Associate Editor for the Journal of Molecular Diagnostics.